Deals
Covidien to Buy Jerusalem-Based Oridion for $346 Million
This article is for subscribers only.
Covidien Plc agreed to buy Oridion Systems Ltd., an Israeli maker of devices for patient breathing safety, for $346 million.
Covidien will pay about 21.08 Swiss francs ($23) a share, Jerusalem-based Oridion said today in a statement, 75 percent more than Oridion’s closing price yesterday. Oridion rose 71 percent to 20.50 francs at 4:50 p.m. in Zurich, where the company is listed on the Swiss stock exchange. Covidien, which is based in Dublin and run from Mansfield, Massachusetts, fell